XML 21 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Current assets:    
Cash and cash equivalents $ 154,257 $ 126,685
Short-term investments 72,459 130,017
Accounts receivable 12,702 6,341
Deferred income tax 3,139 3,139
Prepaid expenses and other current assets 5,794 7,546
Total current assets 248,351 273,728
Property and equipment, net of accumulated depreciation and amortization 634 766
Patents, net of accumulated amortization 269,435 288,432
Goodwill 30,149 30,149
Other assets 351 318
Total assets 548,920 593,393
Current liabilities:    
Accounts payable and accrued expenses 16,564 11,555
Accrued patent investment costs 4,000 4,000
Royalties and contingent legal fees payable 17,777 10,447
Total current liabilities 38,341 26,002
Deferred income taxes 3,343 4,874
Other liabilities 310 319
Total liabilities 41,994 31,195
Commitments and contingencies (Note 5)      
Stockholders' equity:    
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding 0 0
Common stock, par value $0.001 per share; 100,000,000 shares authorized; 50,104,675 and 49,385,057 shares issued and outstanding as of September 30, 2014 and December 31, 2013, respectively 50 49
Treasury stock, at cost, 1,729,408 shares as of September 30, 2014 and December 31, 2013 (34,640) (34,640)
Additional paid-in capital 648,760 653,314
Accumulated comprehensive loss (781) (947)
Accumulated deficit (111,851) (62,066)
Total Acacia Research Corporation stockholders' equity 501,538 555,710
Noncontrolling interests in operating subsidiaries 5,388 6,488
Total stockholders' equity 506,926 562,198
Total liabilities and stockholders' equity $ 548,920 $ 593,393